AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function
11/12/2025 – AB Science today announced the publication of a new article on MedRxiv, presenting a post-hoc subgroup analysis of the phase 2b/3 AB10015 study